Patents by Inventor Wei Peng YONG

Wei Peng YONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MicroRNA biomarker for the diagnosis and treatment of gastric cancer
    Patent number: 10767230
    Abstract: Disclosed are methods of determining the likelihood of a subject having or developing a gastric cancer. The methods comprise measuring the expression level of at least one miRNA having at least 90% sequence identity with an miRNA as described herein in a non-cellular biofluid sample obtained from the subject, wherein differential expression of miRNA expression in the sample obtained from the subject, as compared to a control, may be indicative of the subject having gastric cancer and wherein the miRNA may be either an miRNA listed as “up-regulated” or an miRNA listed as “down-regulated”. Also disclosed is a method of determining the likelihood of a subject having or developing a stage of a gastric cancer.
    Type: Grant
    Filed: August 11, 2015
    Date of Patent: September 8, 2020
    Assignees: Agency for Science, Technology and Research, National University of Singapore, National University Hospital (Singapore) Pte Ltd.
    Inventors: Heng-phon Too, Lihan Zhou, Ruiyang Zou, Khay Guan Yeoh, Bok Yan So, Feng Zhu, Wei Peng Yong
  • MicroRNA Biomarker for the Diagnosis of Gastric Cancer
    Publication number: 20170233822
    Abstract: Disclosed are methods of determining the likelihood of a subject having or developing a gastric cancer. The methods comprise measuring the expression level of at least one miRNA having at least 90% sequence identity with an miRNA as described herein in a non-cellular biofluid sample obtained from the subject, wherein differential expression of miRNA expression in the sample obtained from the subject, as compared to a control, may be indicative of the subject having gastric cancer and wherein the miRNA may be either an miRNA listed as “up-regulated” or an miRNA listed as “down-regulated”. Also disclosed is a method of determining the likelihood of a subject having or developing a stage of a gastric cancer.
    Type: Application
    Filed: August 11, 2015
    Publication date: August 17, 2017
    Inventors: Heng-phon TOO, Lihan ZHOU, Ruiyang ZOU, Khay Guan YEOH, Bok Yan SO, Feng ZHU, Wei Peng YONG